Neutrophil to lymphocyte ratio in Behçet's disease as a marker of disease activity

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 23, Issue 4, 2014, Pages 65-67

  Rifaioglu, Emine Nur ^a   Şen, Bilge Bülbül ^a   Ekiz, Özlem ^a   Dogramaci, Asena Cigdem ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Beh et's disease; C reactive protein; Inflammation; Neutrophil to lymphocyte ratio

Indexed keywords

C REACTIVE PROTEIN;

ACNE; ADULT; ARTHRITIS; ARTICLE; BEHCET DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ACTIVITY; DISEASE MARKER; EPIDIDYMITIS; ERYTHEMA NODOSUM; FEMALE; GENITAL ULCER; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; RETROSPECTIVE STUDY; THROMBOPHLEBITIS; IMMUNOLOGY; LEUKOCYTE COUNT; MIDDLE AGED; NEUTROPHIL;

ADULT; BEHCET SYNDROME; FEMALE; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; RETROSPECTIVE STUDIES;

EID: 84920496809     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: 10.15570/actaapa.2014.16     Document Type: Article

References (23)

1. Pineton De Chambrun M, Wechsler B, Geri G, Cacoub P, Saadoun D. New insights into the pathogenesis of Behcet's disease. Autoimmun Rev. 2012;11:687-98.
2. Macey M, Hagi-Pavli E, Stewart J, Wallace GR, Stanford M, Shirlaw P, et al. Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behcet's disease. Rheumatology (Oxford). 2011;50:1849-59.
3. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet. 1990;335:1078-80.
4. Neves FS, Carrasco S, Goldenstein-Schainberg C, Goncalves CR, De Mello SB. Neutrophil hyperchemotaxis in Behcet's disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses. Clin Rheumatol. 2009;28:1403-10.
5. Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther. 2013;11:55-9.
6. Ozturk ZA, Kuyumcu ME, Yesil Y, Savas E, Yýldýz H, Kepekçi Y, et al. Is there a link between neutrophil-lymphocyte ratio and microvascular complications in geriatric diabetic patients? J Endocrinol Invest. 2013;36:593-9.
7. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88:218-30.
8. Ahsen A, Ulu MS, Yuksel S, Demir K, Uysal M, Erdogan M, et al. As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation. 2013;36:1357-62.
9. Celikbilek M, Dogan S, Ozbakýr O, Zararsýz G, Kücük H, Gürsoy S, et al. Neutrophillymphocyte ratio as a predictor of disease severity in ulcerative colitis. J Clin Lab Anal. 2013;27:72-6.
10. Sarican T, Ayabakan H, Turkmen S, Kalaslioglu V, Baran F, Yenice N. Homocysteine: an activity marker in Behçet's disease? J Dermatol Sci. 2007;45:121-6.
11. Emmi G, Silvestri E, Squatrito D, D'Elios MM, Ciucciarelli L, Prisco D, et al. Behçet's syndrome pathophysiology and potential therapeutic targets. Intern Emerg Med. 2014;9:257-65.
12. Cho S, Kim J, Cho SB, Zheng Z, Choi MJ, Kim DY, et al. Immunopathogenic characterization of cutaneous inflammation in Behçet's disease. J Eur Acad Dermatol Venereol. 2014;28:51-7.
13. Tuzun B, Tuzun Y, Yurdakul S, Hamuryudan V, Yazici H, Ozyazgan Y. Neutrophil chemotaxis in Behcet's syndrome. Ann Rheum Dis. 1999;58:658.
14. Kapsimali VD, Kanakis MA, Vaiopoulos GA, Kaklamanis PG. Etiopathogenesis of Behcet's disease with emphasis on the role of immunological aberrations. Clin Rheumatol. 2010;29:1211-16.
15. Aygunduz M, Bavbek N, Ozturk M, Kaftan O, Kosar A, Kirazli S. Serum beta 2-microglobulin reflects disease activity in Behcet's disease. Rheumatol Int. 2002;22:5-8.
16. Sari RA, Kiziltunc A, Taysi S, Akdemir S, Gundogdu M. Levels of soluble E-selectin in patients with active Behcet's disease. Clin Rheumatol. 2005;24:55-59.
17. Balta I, Balta S, Koryurek OM, Demirkol S, Mikhailidis DP, Celik T, et al. Serum endocan levels as a marker of disease activity in patients with Behçet disease. J Am Acad Dermatol. 2014;70:291-6.
18. Sen BB, Rifaioglu EN, Ekiz O, Inan MU, Sen T, Sen N. Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis. Cutan Ocul Toxicol. 2014;33:223-7.
19. Torun S, Tunc BD, Suvak B, Yildiz H, Tas A, Sayilir A, et al. Assessment of neutrophillymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity. Clin Res Hepatol Gastroenterol. 2012;36:491-7.
20. Ansar W, Ghosh S. C-reactive protein and the biology of disease. Immunol Res. 2013;56:131-42.
21. Rowe IF, Deans AC. Serum C-reactive protein measurement in pyoderma gangrenosum. Dermatologica. 1986;173:216-9.
22. Turner D, Mack DR, Hyams J, Le Leiko N, Otley A, Markowitz J, et al. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis. J Crohns Colitis. 2011;5:423-9.
23. Coskun B, Saral Y, Gödekmerdan A, Erden I, Coskun N. Activation markers in Behçet's disease. Skinmed. 2005;4:282-6.